Newsroom

Sorted by: Latest

-

Comtech Announces Leadership Updates

CHANDLER, Ariz.--(BUSINESS WIRE)--October 14, 2026-- Comtech Telecommunications Corp. (NASDAQ: CMTL) (“Comtech” or the “Company”), a global communications technology leader, today announced the appointments of Richard ("Rich") Nyren as Executive Vice President, Finance, and Amy Rothstein-Hovey as General Counsel. The appointments are part of a carefully planned transition as the Company prepares for its next chapter following the anticipated closing of the sale of most of its Satellite & Sp...
-

From Spin Wave to Superconducting Circuit: Argonne Finds One-Way Street for Quantum Information

LEMONT, Ill.--(BUSINESS WIRE)--In a result published in Physical Review Letters, scientists build a link with a spin wave, advancing new functions in hybrid quantum systems....
-

All State Fastener Expands Heavy Truck Distribution Operations with New Central Ohio Distribution Center

CHILLICOTHE, Ohio--(BUSINESS WIRE)--All State Fastener (ASF), a family-owned global distributor of standard and engineered fasteners and related production components, today announced the grand opening of its newest distribution facility located in Chillicothe, Ohio—significantly expanding the company's infrastructure serving the heavy truck manufacturing industry and its extensive network of tier suppliers. The new facility represents a major expansion of ASF's presence in the strategically im...
-

Susan G. Komen®, Rep. Emilia Sykes and Northeast Ohio Advocates Discuss Barriers to Breast Cancer Diagnosis That Could Save Lives

CANTON, Ohio--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading nonprofit breast cancer organization, today joined Rep. Emilia Sykes, Northeast Ohio breast cancer advocates and Cleveland Clinic Mercy Hospital Cancer Center leaders for a community roundtable focused on improving access to timely breast cancer imaging for patients across Ohio. More than 11,000 people in Ohio will be diagnosed with breast cancer in 2026 and more than 1,500 will die from the disease this year alone.The roundtabl...
-

NiSource to Release Third Quarter 2026 Financial Results and Host Conference Call on October 28

MERRILLVILLE, Ind.--(BUSINESS WIRE)--NiSource Inc. (NYSE: NI) today announced that the company will release third quarter 2026 financial results on October 28, 2026, before US financial markets open and will host a conference call that day at 11 a.m. EDT (10 a.m. CT) to review third quarter 2026 financial results and provide a general business update. All interested parties may listen to the conference call live on October 28 by logging onto the NiSource website at www.nisource.com. A link on t...
-

The Chemours Company (CC) Investors: December 7, 2026, Deadline in Securities Fraud Class Action Lawsuit – Contact Kessler Topaz Meltzer & Check, LLP

RADNOR, Pa.--(BUSINESS WIRE)--Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, informs investors that a securities fraud class action lawsuit has been filed against The Chemours Company (“Chemours”) (NYSE: CC) on behalf of those who purchased or acquired Chemours securities between February 20, 2026 and August 4, 2026, inclusive. The lawsuit is filed in the United States District Court for the District of Delaware and is captioned Da...
-

KBRA Assigns Preliminary Ratings to CROSS 2026-NQM12 Mortgage Trust

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to ten classes of mortgage pass-through certificates from CROSS 2026-NQM12 Mortgage Trust, an RMBS transaction issued under the CROSS shelf, where Hildene-CCC Loan Acquisition II, LLC and CrossCountry Capital are the co-sponsors. This $663.3 million transaction is collateralized by a pool of 1,361 residential mortgages, including a meaningful concentration of collateral that KBRA considers to be “non-prime” (77.7%), with fixed-rate mor...
-

FDA Expands ANKTIVA® Approval for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer to Cover Both Papillary and CIS Disease

CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the U.S. Food and Drug Administration (FDA) has expanded the approved indication for ANKTIVA® (nogapendekin alfa inbakicept-pmln) in combination with Bacillus Calmette-Guérin (BCG) to include patients with BCG-unresponsive NMIBC with papillary-only tumors. The expanded FDA label reads as follows: ANKTIVA, in combination with Bacillus Calmette-Guérin (BCG), is in...
-

Publix Announces Officer Retirement and Promotions in Industrial Operations and Finance

LAKELAND, Fla.--(BUSINESS WIRE)--Publix CEO Kevin Murphy announced officer promotions effective Jan. 1, 2027, and the retirement of Senior Vice President of Industrial Operations Mike Smith. Smith plans to retire at the end of the year after 43 years of dedicated service. With Smith’s retirement, Vice President of Distribution and Transportation Mike Lester will be promoted to senior vice president of industrial operations, and Director of Transportation and Maintenance James Sadler will be pro...
-

BXP Completes Initial Sale of Partial Interest in 343 Madison Avenue Development

BOSTON--(BUSINESS WIRE)--BXP, Inc. (NYSE: BXP), the largest publicly traded developer, owner, and manager of premier workplaces in the United States, announced today that it has closed the sale of a 10.6% equity interest in the development of 343 Madison Avenue in Midtown Manhattan, New York, to AVRS Partners, a New York-based real estate investment firm specializing in identifying and acquiring exceptional real estate assets across the United States and Europe. “343 Madison Avenue demonstrates...